Search the Newsreel

LiveRamp (RAMP) Stock Faces Deal Ceiling Despite Margin Reset

LiveRamp (RAMP) reported strong Q1 2027 earnings, with increased revenue, net income, and EPS, alongside a significant improvement in net margin to 18.6%. Despite these positive operational results and a valuation analysis suggesting a genuine discount, the stock's muted reaction and nearly flat performance …

Royal Bank of Canada Grows Stock Holdings in Veracyte, Inc. $VCYT

Royal Bank of Canada increased its stake in Veracyte, Inc. (NASDAQ:VCYT) by 66.4% in the first quarter, acquiring an additional 228,720 shares, bringing its total to 573,096 shares valued at approximately $18.46 million. This move is part of a broader trend of institutional investors …

Innovation Beverage Group Ltd (IBG) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Innovation Beverage Group Ltd (IBG), detailing its current stock price, market capitalization, and analyst ratings. Based on zero analysts, the target price is USD 4.00, representing a potential upside of +566.44%. The article highlights a lack of …

Monster Beverage (NASDAQ:MNST) Price Target Raised to $101.00

Piper Sandler has increased its price target for Monster Beverage (NASDAQ:MNST) to $101.00 from $94.00, maintaining an "overweight" rating. This adjustment comes after Monster Beverage exceeded quarterly expectations with $0.60 EPS and $2.50 billion in revenue, reflecting 20.2% year-over-year growth driven by international demand. …

Molson Coors Q2 Earnings Beat Estimates on Pricing and Cost Savings

Monster Beverage Beats Q2 Earnings on Broad-Based Sales Growth

Monster Beverage Corp. stock underperforms Friday when compared to competitors

Shares of Monster Beverage Corp. (MNST) fell by 4.04% on Friday, closing at $90.36, despite a generally positive trading day for the broader market. The S&P 500 Index (SPX) increased by 0.62% and the Dow Jones Industrial Average (DJIA) rose by 0.28%. This marks …

Monster Beverage’s Q2 Earnings Crossed $2.5 Billion But Margins Told a Different Story.

Verastem (NASDAQ:VSTM) Shares Gap Up Following Better-Than-Expected Earnings

Molson Coors Beverage (TAP) Is Seeking Acquisitions For Horizon 2030

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Molson Coors Beverage (NYSE:TAP) is pursuing acquisitions as part of its Horizon 2030 growth strategy. The company plans to invest in growth initiatives …

Splash Beverage Group Inc (SBEV) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Splash Beverage Group Inc (SBEV), indicating that no earnings forecast score is currently available, but the Beverages industry average is 7.12. Analysts have set a consistent price target of $40.00, representing a significant upside potential. The company's …

Verastem, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:VSTM) 2026-08-07

Monster Beverage Corp 2026: Revenue $2.54B, EPS $0.59— 10-Q Summary

Monster Beverage Corp reported strong financial results for the 2026 quarter, with revenue reaching $2.54 billion and diluted EPS at $0.59. This growth, reflecting a 20.2% increase in revenue year-over-year, was primarily driven by heightened global demand for Monster Energy products and significant international …

VERAXA Biotech (NASDAQ: VRXA) Advances VXA-222 Cancer Program While Expanding Patent Portfolio for Next-G

VERAXA Biotech (NASDAQ: VRXA) has advanced its VXA-222 bispecific antibody-drug conjugate (bsADC) program into the next development stage after successfully completing the discovery phase with OmniAb Inc. The company will now focus on engineering the final therapeutic candidate and conducting preclinical validation. VERAXA also …

Monster Beverage Corporation (NASDAQ:MNST) Given Average Recommendation of "Moderate Buy" by Brokerages

Analysts have issued an average "Moderate Buy" rating for Monster Beverage Corporation (NASDAQ:MNST), with a 12-month price target of $94.65. The company recently surpassed Q2 earnings and revenue estimates, reporting EPS of $0.60 and a 20.2% increase in revenue to $2.54 billion, driven by …

Vera Therapeutics grants equity inducement awards to new hires

Vera Therapeutics Inc (NASDAQ: VERA) granted inducement equity awards to three new employees, including Chief Regulatory Officer Nancy Bowman, under Nasdaq Listing Rule 5635(c)(4). The awards, consisting of stock options and RSUs, are designed to attract key talent and vest over four years subject …

Molson Coors Beverage Company 2026 Q2 - Results - Earnings Call Presentation (NYSE:TAP) 2026-08-07

Key Points Interested in Molson Coors Beverage Company? Here are five stocks we like better. Molson Coors reaffirmed its fiscal 2026 outlook despite a weak second quarter: constant-currency net sales fell 3.6%, underlying pretax income declined 27.8%, and underlying EPS dropped 22.9% year over …

Monster (NASDAQ:MNST) Surprises With Q2 CY2026 Sales

Monster (NASDAQ:MNST) Surprises With Q2 CY2026 Sales Energy drink company Monster Beverage (NASDAQ:MNST) reported Q2 CY2026 results exceeding the market's revenue expectations , with sales up 20.2% year on year to $2.54 billion. Its non-GAAP profit of $0.60 per share was 3% above analysts' …

Monster Beverage Q2 Earnings Call Highlights

Monster Beverage reported record Q2 2026 net sales of $2.54 billion, a 20.2% year-over-year increase, driven by strong international growth and the Monster Energy drinks segment. Despite higher costs for aluminum, freight, and marketing, the company saw adjusted diluted EPS rise by 15.2% to …

MONSTER BEVERAGE CORP : RBC RAISES TARGET PRICE TO $100 FROM $97

RBC has increased its target price for Monster Beverage Corp (MNST.O) shares to $100 from the previous $97. This adjustment suggests a positive outlook from RBC on the company's future stock performance. The news was reported by Reuters.

Verastem Inc (VSTM) (Q2 2026) Earnings Call Highlights: Strong Revenue Rebound and Strategic ...

Verastem Inc (VSTM) reported strong Q2 2026 net product revenues of $25.1 million, reflecting a significant rebound due to improved commercial execution for its LGSOC franchise. The company also secured a non-dilutive royalty financing agreement of up to $75 million, strengthening its balance sheet …

Verastem, Inc. 2026: Revenue $40.08M, EPS ($0.35) — 10-Q Summary

Verastem, Inc. reported its 2026 quarterly results, showing a significant increase in revenue to $40.08M from $2.14M in the prior year, primarily due to the commercial launch of AVMAPKI FAKZYNJA CO-PACK. The company also narrowed its net loss to ($34.67M) and improved diluted loss …

Verastem earnings beat by $0.12, revenue topped estimates

Verastem (NASDAQ: VSTM) reported strong second-quarter results, beating analyst EPS estimates by $0.12 with earnings of $-0.310 and significantly exceeding revenue forecasts at $40.07M against an estimated $23.09M. The company's stock has seen a 20.860% increase in the last three months and a 5.160% …

Earnings call transcript: Verastem beats Q2 2026 estimates, shares jump after hours

Molson Coors Beverage Co (TAP) (Q2 2026) Earnings Call Highlights: Navigating Category ...

This article first appeared on GuruFocus. Release Date: August 06, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Molson Coors Beverage Co (NYSE:TAP) reaffirmed its fiscal 2026 guidance despite external headwinds, demonstrating confidence …

Monster Beverage (MNST) Surpasses Q2 Earnings and Revenue Estimates

Monster Beverage (MNST) reported strong Q2 2026 earnings of $0.60 per share and revenues of $2.54 billion, both exceeding Zacks Consensus Estimates. The company has consistently surpassed earnings and revenue expectations over the past four quarters, with its stock performing well year-to-date. Despite the …

Verastem (VSTM) Reports Q2 Loss, Beats Revenue Estimates

Verastem (VSTM) reported a Q2 loss of $0.35 per share, surpassing the Zacks Consensus Estimate of a $0.46 loss and exceeding prior year's loss of $0.39. The company's revenues for the quarter reached $40.08 million, significantly beating the Zacks Consensus Estimate by 73.12% and …

Monster Beverage Corporation Reveals Climb In Q2 Income

(RTTNews) - Monster Beverage Corporation (MNST) reported earnings for its second quarter that Increases, from last year The company's earnings totaled $584.54 million, or $0.59 per share. This compares with $488.79 million, or $0.50 per share, last year. Excluding items, Monster Beverage Corporation reported …

Monster Beverage Corp (MNST) Q2 2026 Earnings

Monster Beverage Corp (MNST) reported a strong Q2 2026, surpassing analyst expectations with EPS of $0.60 against an estimated $0.58, and revenue of $2.54 billion compared to an estimated $2.43 billion. The company's international sales significantly contributed to this performance, now accounting for 46% …

Monster Beverage Reports 2026 Second Quarter Financial Results

Monster Beverage Corporation 2026 Second Quarter Highlights Net Sales rise 20.2 percent to $2.54 billion Net Income increases 19.6 percent to $584.5 million (15.7 percent to $590.5 million on a non-GAAP adjusted basis)1 Net Income Per Diluted Share increases 19.0 percent to $0.59 per …

Monster Beverage Overseas Sales Jump 34.6% to $1.16B in Q2

Monster Beverage (NASDAQ: MNST) reported strong Q2 2026 financial results, with net sales increasing 20.2% to $2.54 billion and diluted EPS rising 19.0% to $0.59. International net sales were a significant driver, growing 34.6% to $1.16 billion, representing 46% of total sales. The company …

LiveRamp Holdings, Inc. (NYSE:RAMP) Receives Consensus Recommendation of "Hold" from Brokerages

LiveRamp Holdings, Inc. (NYSE:RAMP) has received a consensus "Hold" recommendation from brokerages, with six of eight analysts rating the stock a hold and two recommending a buy. The average 12-month price target is $40.21, slightly above its current share price of $37.77. The company …

Pacer Advisors Inc. Has $6.44 Million Stake in LiveRamp Holdings, Inc. $RAMP

Pacer Advisors Inc. increased its stake in LiveRamp Holdings, Inc. by 23.2% in the first quarter, now owning 242,816 shares valued at $6.44 million. LiveRamp exceeded quarterly earnings and revenue expectations, reporting $0.65 EPS against a $0.58 consensus and $213.99 million in revenue, a …

FMR LLC discloses 7.6% Veradermics Inc. (MANE) ownership in Schedule 13G

FMR LLC and Abigail P. Johnson have disclosed a 7.6% passive ownership stake in Veradermics Inc. (MANE) common stock through a Schedule 13G filing. The filing indicates beneficial ownership of 3,193,181 shares as of June 30, 2026, with FMR LLC holding sole voting and …

Veracyte Inc (VCYT) Earnings Forecast: Future EPS & Revenue Growth Estimates

Veracyte Inc (VCYT) has an earnings forecast score of 8.46, ranking 126th in the Biotechnology & Medical Research industry. Analysts have set an average price target of $48.00, with a consensus "Buy" rating based on 13 analysts. The company's expected revenue for the next …

Molson Coors (TAP) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended June 2026, Molson Coors Brewing (TAP) reported revenue of $3.1 billion, down 3.3% over the same period last year. EPS came in at $1.58, compared to $2.05 in the year-ago quarter. The reported revenue represents a surprise of +0.24% over …